Menu
Doctor's prescription
Pisa®️
Download Leaflet Listen leaflet
Find here loading...
Eg capsules, pills, syrup, 10mg, etc.
Eurofarma does not sell directly to consumers. The prices presented here are for information purposes only and should be checked directly on the offerors website
{{ sku.name }}
In Stock
Find it now
Product Package Image
Image for illustrative purposes only.
Indication
Pisa®️ (dicloridrato de pramipexol) é indicado para o tratamento dos sinais e sintomas da doença de Parkinson idiopática, podendo ser usado como monoterapia (sem levodopa) ou associado à levodopa.
Active Ingredient
dicloridrato de pramipexol
Concentration
0,375 mg | 0,750 mg | 1,50 mg
Presentation
Comprimido de liberação prolongada 0,375 mg e 0,750 mg: embalagem com 10 e 30 comprimidos. Comprimido de liberação prolongada 1,5 mg: embalagem com 30 comprimidos.
Practical information
Extended Release Tablet
Antiparkisonians
Retention - can only be sold with revenue retention
Doctor's prescription
Contraindication
Pacientes com hipersensibilidade ao pramipexol ou aos excipientes da fórmula. Este medicamento não deve ser utilizado por mulheres grávidas sem orientação médica ou do cirurgião-dentista.
Conscious Use of Medications Manual
So that you can take better care of yourself and those you love, following a safe and effective treatment, we present the manual on the conscious use of medicines. The publication brings together a series of extremely relevant information, presented in a simple and educational way. Access the manual here
Published in: September 22, 2016 
and updated in: July 24, 2024
Se persistirem os sintomas, o médico deverá ser consultado.
Registration 1.0043.1174
Eurofarma
About The Company Areas of Expertise Join Our Staff Media Eurofarma Certifications Warnings Awards and Recognition Visitation Program Where We Operate Press Office Programa +Diverso
Products
Generic Drugs Hospital Nonprescription Drugs Oncology Prescription Drugs
Innovation
Biotechnology Eurolab New Business Conduct Clinical Research With Us Research and Development EurON
Sustainability
Sustainable Report Corporate Governance Environment Annual Report Corporate Responsibility Sustainability Vision Balance Sheet
© Eurofarma 2024
Privacy Policy